Trump to announce new drug pricing agreement.

President Trump is set to announce another round of voluntary drug-pricing agreements today involving Bayer, Takeda, CSL and several midsized biotechnology companies. Under the agreements, participating drugmakers are expected to provide “most-favored-nation,” or MFN, pricing on…